Form 8-K - Current report:
SEC Accession No. 0001193125-25-043405
Filing Date
2025-03-03
Accepted
2025-03-03 07:14:54
Documents
54
Period of Report
2025-03-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d876788d8k.htm   iXBRL 8-K 30886
2 EX-99.1 d876788dex991.htm EX-99.1 45312
3 EX-99.2 d876788dex992.htm EX-99.2 12200
7 GRAPHIC g876788ex99_1p10g1.jpg GRAPHIC 355978
8 GRAPHIC g876788ex99_1p11g1.jpg GRAPHIC 306735
9 GRAPHIC g876788ex99_1p12g1.jpg GRAPHIC 201050
10 GRAPHIC g876788ex99_1p13g1.jpg GRAPHIC 288821
11 GRAPHIC g876788ex99_1p14g1.jpg GRAPHIC 225724
12 GRAPHIC g876788ex99_1p15g1.jpg GRAPHIC 267273
13 GRAPHIC g876788ex99_1p16g1.jpg GRAPHIC 425591
14 GRAPHIC g876788ex99_1p17g1.jpg GRAPHIC 101847
15 GRAPHIC g876788ex99_1p18g1.jpg GRAPHIC 438493
16 GRAPHIC g876788ex99_1p19g1.jpg GRAPHIC 335732
17 GRAPHIC g876788ex99_1p1g1.jpg GRAPHIC 279077
18 GRAPHIC g876788ex99_1p20g1.jpg GRAPHIC 373968
19 GRAPHIC g876788ex99_1p21g1.jpg GRAPHIC 223548
20 GRAPHIC g876788ex99_1p22g1.jpg GRAPHIC 370073
21 GRAPHIC g876788ex99_1p23g1.jpg GRAPHIC 322041
22 GRAPHIC g876788ex99_1p24g1.jpg GRAPHIC 105663
23 GRAPHIC g876788ex99_1p25g1.jpg GRAPHIC 180526
24 GRAPHIC g876788ex99_1p26g1.jpg GRAPHIC 407281
25 GRAPHIC g876788ex99_1p27g1.jpg GRAPHIC 410554
26 GRAPHIC g876788ex99_1p28g1.jpg GRAPHIC 351524
27 GRAPHIC g876788ex99_1p29g1.jpg GRAPHIC 483526
28 GRAPHIC g876788ex99_1p2g1.jpg GRAPHIC 640421
29 GRAPHIC g876788ex99_1p30g1.jpg GRAPHIC 357095
30 GRAPHIC g876788ex99_1p31g1.jpg GRAPHIC 109909
31 GRAPHIC g876788ex99_1p32g1.jpg GRAPHIC 421864
32 GRAPHIC g876788ex99_1p33g1.jpg GRAPHIC 433488
33 GRAPHIC g876788ex99_1p34g1.jpg GRAPHIC 55913
34 GRAPHIC g876788ex99_1p35g1.jpg GRAPHIC 312815
35 GRAPHIC g876788ex99_1p36g1.jpg GRAPHIC 331297
36 GRAPHIC g876788ex99_1p37g1.jpg GRAPHIC 479357
37 GRAPHIC g876788ex99_1p38g1.jpg GRAPHIC 259714
38 GRAPHIC g876788ex99_1p3g1.jpg GRAPHIC 360835
39 GRAPHIC g876788ex99_1p4g1.jpg GRAPHIC 458565
40 GRAPHIC g876788ex99_1p5g1.jpg GRAPHIC 418193
41 GRAPHIC g876788ex99_1p6g1.jpg GRAPHIC 269351
42 GRAPHIC g876788ex99_1p7g1.jpg GRAPHIC 318367
43 GRAPHIC g876788ex99_1p8g1.jpg GRAPHIC 277355
44 GRAPHIC g876788ex99_1p9g1.jpg GRAPHIC 105927
45 GRAPHIC g876788g0303032109215.jpg GRAPHIC 2791
  Complete submission text file 0001193125-25-043405.txt   16865478

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rapp-20250303.xsd EX-101.SCH 2855
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rapp-20250303_lab.xml EX-101.LAB 18736
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rapp-20250303_pre.xml EX-101.PRE 11710
56 EXTRACTED XBRL INSTANCE DOCUMENT d876788d8k_htm.xml XML 3768
Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42121 | Film No.: 25693762
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)